Anti-allergic inflammation drops

Abstract

The invention provides anti-allergic inflammation drops. The anti-allergic inflammation drops are prepared from sodium cromoglycate, diclofenac sodium, racanisodamine hydrochloride, dexamethasone, triamcinolone acetonide, glycyrrhizin and B-vitamins; various medicines are combined to have a synergistic action and have a treatment effect in various links; the anti-allergic inflammation drops have aremarkable pharmaceutical effect and are rapid and effective in disease control; the anti-allergic inflammation drops integrate different functions of various medicines so that the dosage of the single medicine is reduced, the total pharmaceutical effect is improved, the side effect is remarkably reduced, the effect of getting twofold results with half the effort is realized and the curative effect is very satisfactory; the whole scheme is created for allergic diseases, has the characteristics of comprehensively treating, treating both symptoms and root cause of diseases, striving for qualityand accurately positioning and is an innovative therapy based on brand-new acquaintance of a disease theory.

Description

technical field [0001] The invention relates to the field of medicine and hygiene, in particular to an anti-allergic inflammation drop. Background technique [0002] The current anti-allergic drugs for treating allergic inflammation mostly consider the treatment problem from a certain link of the pathological mechanism, and use drugs for a certain main link of the allergic reaction. The disadvantage of this is that it is not enough to completely and effectively control the disease. The 2nd, it is inconvenient to use, and in most cases, need simultaneously more than two kinds of antiallergic preparations joint use, just can take effect, but this compatibility is all not very convenient no matter use or carry. The 3rd, toxic and side effects are big, and single medicine is used for a long time usually, and drug effect reduces, and side effect is obvious, even if combined medicine, time has increased the chance of infection for a long time, easily suffers from bacterial conjunc...

AI Technical Summary

Problems solved by technology

[0002] The current anti-allergic drugs for the treatment of allergic inflammation mostly consider the treatment problem from a certain link of the pathological mechanism, and use drugs for a certain main link of the allergic reaction. The disadvantage of this is that it is not enough to completely and effectively control the disease

The second is that it is inconvenient to use. In most cases, two or more antiallergic preparations need to be used in combination to be effective, but this combination is not very convenient to use or carry.

The third is that the toxic and side effects are large. A single drug is usually used for a long time, the efficacy of the drug is reduced, and the side effects are obvious. Even if it is used in combination, the chance of infection will increase after a long time, and it is easy to suffer from bacterial conjunctivitis.

Fourth, the treatment effect is unstable and varies from person to person, and is also interfered by various factors, which is prone to recurrence and rebound